Abstract Analogs of the luteinizing hormone releasing hormone (LHRH) which are antagonists for controlling ovulation require potency and negligible release of histamine as a side effect. Forty analogs were designed, synthesized and bioassayed in two groups with emphasis upon positions 1, 5 and 6 and upon positions 1, 2 and 3. N-Ac-D-2-Nal1, D-pClPhe2, D-3-Pal3, Ser4, Tyr5, D-Lys6, Leu7, Arg8, Pro9, D-Ala10-NH2 and N-Ac-D-CL2Phe1, D-α-Me-pCIPhe2, D-3-Pal3, Ser4, Tyr5 D-Arg6, Leu7, Arg8, Pro9, D-Ala10-NH2 caused 100% inhibition of ovulation at 0.5 Όg in rats. The former analog showed 12.5% anh-ovulatory activity (AOA) and the latter analog showed 40% AOA at 0.25 (Όg. The neutral Cit6 moiety is unique since it and the basic D-NicLys6 moiety provided peptides comparable in activity. Frequently, D-2-Nal, D-pClPhe and D-CL2Phe are comparable in position 1. Histamine release was substantially low for a D-NicLys6 analog.